ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Mark Dynamics Indonesia Tbk's annualized ROCE % for the quarter that ended in Mar. 2026 was 44.86%.
PT Mark Dynamics Indonesia Tbk (ISX:MARK) ROCE % Explanation
ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.
Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.
PT Mark Dynamics Indonesia Tbk ROCE % Related Terms
PT Mark Dynamics Indonesia Tbk ROCE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
(1) Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Mark Dynamics Indonesia Tbk (ISX:MARK) has a ROCE % of 44.86% as of Mar. 2026.
Is PT Mark Dynamics Indonesia Tbk's ROCE % too high?
PT Mark Dynamics Indonesia Tbk's current ROCE % is 44.86%. The Medical Devices & Instruments industry median ROCE % is 2.20. PT Mark Dynamics Indonesia Tbk's value of 44.86% is 1939.1% above this industry median. Overall, PT Mark Dynamics Indonesia Tbk has a GF Score™ of 75/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Mark Dynamics Indonesia Tbk's ROCE % compare to ISRG and BDX?
PT Mark Dynamics Indonesia Tbk's ROCE % of 44.86% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. PT Mark Dynamics Indonesia Tbk's value of 44.86% is 1939.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Mark Dynamics Indonesia Tbk's current ROCE % of 44.86% is 1939.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Mark Dynamics Indonesia Tbk's current ROCE % is 44.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Mark Dynamics Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Mark Dynamics Indonesia Tbk (ISX:MARK) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp114,906.96, compared to a current price of Rp990.00 — trading 99.1% below its estimated fair value. The current ROCE % is 44.86% and 1939.1% above the Medical Devices & Instruments industry median of 2.20. PT Mark Dynamics Indonesia Tbk's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For PT Mark Dynamics Indonesia Tbk (ISX:MARK), the current ROCE % is 44.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Mark Dynamics Indonesia Tbk (ISX:MARK) Overvalued in 2026?
Based on GuruFocus' analysis, PT Mark Dynamics Indonesia Tbk stock appears to be undervalued.
The current stock price of Rp990.00 is trading 99.1% below its estimated GF Value™ of Rp114,906.96.
GuruFocus considers PT Mark Dynamics Indonesia Tbk to be Significantly Undervalued.
Key valuation signals for ISX:MARK:
ROCE %: 44.86%
GF Value™: Rp114,906.96 vs. price of Rp990.00 (99.1% below fair value)
Industry Position: 1939.1% above the Medical Devices & Instruments median
No single metric tells the full story. See the ISX:MARK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Mark Dynamics Indonesia Tbk Business Description
AddressJalan Raya Medan Lubuk Pakam Highway Km. 19,5, Jalan Pelita Barat No. 2, Deli Serdang, Kawasan Insdustri Medan Star, Tanjung Morawa, North Sumatera, Medan, IDN, 20362
PT Mark Dynamics Indonesia Tbk is a company engaged in the manufacturing industry of ceramic-based hand formers. The company's products include examination formers, surgical formers, household formers, custom-made formers, and industrial formers for export purposes. The products of the company are mainly exported to nitrile and latex glove manufacturers in Malaysia, Thailand, China, and the United States. The company also distributes its products in Indonesia. The company generates the majority of its revenue from the sale of Glove Mould.
75GF Score
Get the complete analysis for ISX:MARK
ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MARK has been successfully added to your 
